Company Valuation: Kobayashi Pharmaceutical Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 7,04,427 6,50,295 5,03,841 4,63,131 4,03,511 5,17,397 - -
Change - -7.68% -22.52% -8.08% -12.87% 28.22% - -
Enterprise Value (EV) 1 5,96,011 5,46,554 4,24,992 3,98,232 3,33,575 4,57,619 4,47,936 4,39,821
Change - -8.3% -22.24% -6.3% -16.24% 37.19% -2.12% -1.81%
P/E 35.8x 34.8x 25.3x 46x 110x 46.7x 38.3x 31x
PBR 3.59x 3.47x 2.47x 2.18x 1.92x 2.44x 2.38x 2.3x
PEG - 12.08x 7.7x -0.9x -1.7x 0x 1.7x 1.3x
Capitalization / Revenue 4.54x 3.91x 2.9x 2.8x 2.43x 3.03x 2.88x 2.77x
EV / Revenue 3.84x 3.29x 2.45x 2.4x 2.01x 2.68x 2.5x 2.35x
EV / EBITDA 19.3x 17.1x 13.3x 12.1x 14.1x 20.9x 17x 14.8x
EV / EBIT 22.9x 20.5x 16.5x 16x 22.4x 36.1x 25.9x 20.5x
EV / FCF 31.8x 31.1x -350x -29.2x 68.5x 39.7x 30x 25.7x
FCF Yield 3.15% 3.22% -0.29% -3.42% 1.46% 2.52% 3.34% 3.89%
Dividend per Share 2 83 90 101 102 104 106 110.8 114.3
Rate of return 0.92% 1% 1.49% 1.64% 1.92% 1.52% 1.59% 1.64%
EPS 2 252.4 259.6 268.2 135.4 49.19 149 181.7 224.4
Distribution rate 32.9% 34.7% 37.7% 75.3% 211% 71.2% 60.9% 50.9%
Net sales 1 1,55,252 1,66,258 1,73,455 1,65,600 1,65,742 1,70,818 1,79,450 1,86,870
EBITDA 1 30,900 32,027 31,837 32,800 23,600 21,844 26,388 29,650
EBIT 1 26,065 26,669 25,780 24,860 14,923 12,665 17,300 21,492
Net income 1 19,715 20,022 20,338 10,067 3,656 11,050 13,688 16,548
Net Debt 1 -1,08,416 -1,03,741 -78,849 -64,899 -69,936 -59,778 -69,461 -77,576
Reference price 2 9,040.00 9,030.00 6,790.00 6,230.00 5,428.00 6,960.00 6,960.00 6,960.00
Nbr of stocks (in thousands) 77,923 72,015 74,203 74,339 74,339 74,339 - -
Announcement Date 04/02/22 14/02/23 09/02/24 10/02/25 10/02/26 - - -
1JPY in Million2JPY
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
47.16x2.71x21.17x1.51% 327.85Cr
24.97x4.72x17.28x2.56% 40TCr
34.04x5.15x21.42x1.73% 26TCr
19.38x2.92x12.91x3.24% 14TCr
27.43x4.01x16.72x2.13% 7.92TCr
18.01x4.28x20.42x4.73% 6.64TCr
58.17x8.26x32.24x0.26% 5.2TCr
41.8x6.63x29.17x2.26% 5.05TCr
36.6x2.62x14.17x1.38% 3.79TCr
26.08x1.93x12.3x1.93% 2.3TCr
Average 33.36x 4.32x 19.78x 2.17% 11TCr
Weighted average by Cap. 28.95x 4.63x 18.89x 2.37%

Y-o-Y evolution of P/E

Valuation ratios - P/E - Kobayashi Pharmaceutical Co., Ltd.

Historical PBR trend

Valuation ratios - PBR - Kobayashi Pharmaceutical Co., Ltd.

Evolution Enterprise Value / Sales

Valuation ratios - VE_REV - Kobayashi Pharmaceutical Co., Ltd.

Change in Enterprise Value/EBITDA

Valuation ratios - VE_EBITDA - Kobayashi Pharmaceutical Co., Ltd.


Year-on-year evolution of the Yield

Valuation ratios - Yield - Kobayashi Pharmaceutical Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 4967 Stock
  4. Valuation Kobayashi Pharmaceutical Co., Ltd.